CoChat

Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer: ARID mutations in MSI CRC

Open access
Cajuso, Tatiana, Hänninen, Ulrika A., Kondelin, Johanna, Gylfe, Alexandra E., Tanskanen, Tomas, Katainen, Riku, Pitkänen, Esa, Ristolainen, Heikki, Kaasinen, Eevi, Taipale, Minna, Taipale, Jussi, Böhm, Jan, Renkonen-Sinisalo, Laura, Mecklin, Jukka-Pekka, Järvinen, Heikki, Tuupanen, Sari, Kilpivaara, Outi, Vahteristo, Pia · 2014 · International Journal of Cancer
Cited by 125

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

ARID1A has been identified as a novel tumor suppressor gene in ovarian cancer and subsequently in various other tumor types. ARID1A belongs to the ARID domain containing gene family, which comprises of 15 genes involved, for example, in transcriptional regulation, proliferation and chromatin remodeling. In this study, we used exome sequencing data to analyze the mutation frequency of all the ARID domain containing genes in 25 microsatellite unstable (MSI) colorectal cancers (CRCs) as a first systematic effort to characterize the mutation pattern of the whole ARID gene family. Genes which fulfilled the selection criteria in this discovery set (mutations in at least 4/25 [16%] samples, including at least one nonsense or splice site mutation) were chosen for further analysis in an independent validation set of 21 MSI CRCs. We found that in addition to ARID1A, which was mutated in 39% of the tumors (18/46), also ARID1B (13%, 6/46), ARID2 (13%, 6/46) and ARID4A (20%, 9/46) were frequently mutated. In all these genes, the mutations were distributed along the entire length of the gene, thus distinguishing them from typical MSI target genes previously described. Our results indicate that in addition to ARID1A, other members of the ARID gene family may play a role in MSI CRC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijc.28705

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 125

Metadata

Authors
Cajuso, T., Hänninen, U. A., Kondelin, J., Gylfe, A. E., Tanskanen, T., Katainen, R., Pitkänen, E., Ristolainen, H., Kaasinen, E., Taipale, M., Taipale, J., Böhm, J., Renkonen-Sinisalo, L., Mecklin, J.-P., Järvinen, H., Tuupanen, S., Kilpivaara, O., & Vahteristo, P.
Venue
International Journal of Cancer
Publisher
Wiley
Published
2014-01-13
Volume
135
Issue
3
Pages
611-623
ISSN
0020-7136 (ISSN-L)
OpenAlex
W1596380405
Cited by
125
References
9
FWCI
8.51
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer: ARID mutations in MSI CRC. https://app.cochat.ai/papers/10.1002/ijc.28705
The paper
Cajuso, T., Hänninen, U. A., Kondelin, J., Gylfe, A. E., Tanskanen, T., Katainen, R., Pitkänen, E., Ristolainen, H., Kaasinen, E., Taipale, M., Taipale, J., Böhm, J., Renkonen-Sinisalo, L., Mecklin, J.-P., Järvinen, H., Tuupanen, S., Kilpivaara, O., & Vahteristo, P. (2014). Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer: ARID mutations in MSI CRC. International Journal of Cancer. https://doi.org/10.1002/ijc.28705

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.